Surman, Craig B. H. http://orcid.org/0000-0003-1677-0686
Walsh, Daniel M.
Article History
Accepted: 29 January 2022
First Online: 4 March 2022
Declarations
:
: No sources of funding were used to assist with the preparation of this manuscript.
: Dr. Craig Surman, MD, has received, in his lifetime, consulting fees from Eisai, McNeil, NLS Pharma, Nutricia, Pfizer, Adlon/Purdue, Rhodes, Shire, Somaxon, Sunovion, Supernus, Takeda, and Teva; payments for lectures from Alcobra, Arbor, McNeil, Janssen, Janssen-Ortho, Novartis, Shire, Reed/MGH Academy (funded by multiple companies), and GME CME (funded by multiple companies); royalties from Berkeley/Penguin for <i>“FASTMINDS” How to Thrive if You have ADHD (or Think you Might)</i>” and from Humana/Springer for <i>ADHD in Adults: A Practical Guide to Evaluation and Management</i>. Dr. Surman has also conducted clinical research at Massachusetts General Hospital supported by Abbot, Cephalon, Hilda and Preston Davis Foundation, Eli Lilly, Magceutics/Neurocentria, Jazz, Johnson & Johnson/McNeil, Lundbeck, Merck, Nordic Naturals, Shire, and Takeda. Daniel Walsh has no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: CBHS: Direction of literature search and analysis of results, outline and draft of entire manuscript, editing and final revision of manuscript. DMW: Conduct of literature search, draft of methods and results sections, editing of manuscript.